Dana-Farber Cancer Institute /ID# 92494

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

17p Deletion, Cancer of the Blood and Bone Marrow, Chronic Lymphocytic Leukemia

Studies at this site

• A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion — Completed